Patents Assigned to LIFEMINE THERAPEUTICS, INC.
  • Human therapeutic targets and modulators thereof
    Patent number: 12243623
    Abstract: Among other things, the present disclosure provides technologies for efficient and effective identification of ETaGs, for example, from fungi genomes. In some embodiments, provided technologies are particularly useful for identifying mammalian targets of biosynthetic products of fungi. In some embodiments, provided technologies are particularly useful for identifying and/or prioritizing human targets for drug development. In some embodiments, provided technologies are particularly useful for developing modulators for human targets based on biosynthetic products of fungi.
    Type: Grant
    Filed: July 13, 2023
    Date of Patent: March 4, 2025
    Assignee: LifeMine Therapeutics, Inc.
    Inventors: John Baxter Biggins, Brian Roger Bowman, Gregory L. Verdine
  • Human therapeutic targets and modulators thereof
    Patent number: 11749375
    Abstract: Among other things, the present disclosure provides technologies for efficient and effective identification of ETaGs, for example, from fungi genomes. In some embodiments, provided technologies are particularly useful for identifying mammalian targets of biosynthetic products of fungi. In some embodiments, provided technologies are particularly useful for identifying and/or prioritizing human targets for drug development. In some embodiments, provided technologies are particularly useful for developing modulators for human targets based on biosynthetic products of fungi.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: September 5, 2023
    Assignee: LIFEMINE THERAPEUTICS, INC.
    Inventors: John Baxter Biggins, Brian Roger Bowman, Gregory L. Verdine